Publication | Closed Access
Doxorubicin Disaccharide Analogue: Apoptosis-Related Improvement of Efficacy In Vivo
64
Citations
20
References
1997
Year
The high antitumor activity of MEN 10755 in human tumor xenografts, including doxorubicin-resistant xenografts, and its unique pharmacologic and biologic properties make this disaccharide analogue a promising candidate for clinical evaluation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1